+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

5G-enabled Medical Devices Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 192 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716124
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The fast-evolving 5G-enabled medical devices market is transforming healthcare delivery, helping senior leaders advance modern care infrastructure with seamless connectivity and enhanced data visibility. This deep integration of technology and clinical processes sets a new standard for patient-centered, agile care operations.

Market Snapshot: Growth and Expansion of the 5G-Enabled Medical Devices Market

The global 5G-enabled medical devices market is on a significant growth trajectory, with an estimated valuation of USD 991.10 million in 2024, set to reach USD 1.22 billion by 2025, and projected to grow to USD 5.38 billion by 2032 at a CAGR of 23.56%. This market expansion is fueled by rising demand for high-speed, real-time connectivity supporting timely clinical decisions, more efficient remote monitoring, and integrated healthcare workflows. Continued investment in digital infrastructure allows organizations to streamline operations and align with shifting regulatory as well as patient-centered priorities, providing a stable foundation for scalable and standards-based technology adoption.

Scope & Segmentation: Strategic Dimensions for Senior Leaders

Detailed market segmentation provides essential insights for executives planning digital transformation, optimizing organizational models, and meeting objectives for diverse healthcare environments. Understanding these segment dynamics allows for informed investments and improved patient and operational outcomes.

  • Product Types: Diagnostic systems such as imaging and point-of-care devices support prompt and informed clinical decisions. Monitoring devices for cardiac, glucose, and respiratory functions offer continuous oversight. Therapeutic devices, including infusion pumps and neurostimulators, help enable timely interventions and disease management.
  • Applications: Technologies enable asset tracking, more efficient supply chain management, remote patient monitoring, and rapid response. Integration with smart hospital systems enhances care coordination and overall patient engagement.
  • End Users: Hospitals, ambulatory care centers, clinics, homecare, and telehealth providers leverage advanced connectivity to deliver care both on-site and virtually, strengthening operational adaptability.
  • Connectivity Types: Non-standalone and standalone 5G networks, private cellular options, mmWave, and sub-6 GHz frequencies give organizations the tools to balance flexible infrastructure deployment with demand for robust security.
  • Network Architectures: Hybrid, enterprise, public operator, and MVNO networks allow alignment with specific compliance, governance, and customization needs.
  • Components: Essential elements, including antennas, sensors, and communication modules, are complemented by services for consulting, integration, analytics, lifecycle support, and mobility software to help maximize device performance and deployment.
  • Regions: Market development in the Americas, Europe, Asia-Pacific, and Middle East & Africa is defined by local infrastructure advancement and unique regulatory considerations, shaping both investment focus and progress timelines.
  • Company Coverage: Leading and emerging suppliers prioritize modular design and interoperability, enabling seamless adoption and future scalability as care delivery evolves.

Key Takeaways for Senior Decision-Makers

  • Building 5G-enabled infrastructure supports agile, responsive care delivery by assuring continuous data flow and strengthening coordination across care environments.
  • Utilizing private and hybrid 5G networks allows organizations to reinforce security frameworks and address rising data privacy standards in the healthcare sector.
  • Adopting modular, open-standards device architectures eases integration into existing IT investments and positions healthcare entities for upcoming regulatory and delivery model shifts.
  • Forming partnerships with telecommunications and analytics specialists expands internal capabilities and supports the long-term reliability of virtual and decentralized care services.
  • Deploying regionally tailored technology strategies ensures that investments align with local needs and regulatory contexts, helping maximize both resilience and return on innovation.
  • Clear market segmentation informs smarter allocation of capital resources, encouraging operational improvements and technological advancement as organizational expertise evolves.

Tariff Impact: Navigating Supply Chain Adaptability

Recent changes in tariff regulations, notably within the United States, have led manufacturers to re-examine sourcing and production models. Many have adopted nearshoring and localized strategies to mitigate risks from policy fluctuations. By designing modular devices and maintaining close collaboration with telecom partners, businesses can foster ongoing innovation and uphold high standards even when facing supply chain disruption.

Methodology & Data Sources

This analysis is grounded in interviews with senior healthcare executives, specialist industry insights, and comprehensive reviews of relevant regulatory frameworks. The triangulated approach delivers robust findings and actionable recommendations, equipping leadership teams with reliable data for confident business decisions.

Why This Report Matters

  • Offers strategic guidance for investment in scalable, 5G-enabled medical technology to drive both clinical performance and operational goal achievement.
  • Presents actionable solutions for managing regulatory complexity and supply chain uncertainty, based on region-specific market characteristics.
  • Aligns executive planning and system modernization with evolving sector trends to support continuous organizational and clinical improvement.

Conclusion

5G-enabled medical devices are advancing care quality and supporting more connected, coordinated delivery models. Senior leaders can use these insights to inform digital transformation and enable sustained clinical progress.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of 5G connectivity in remote patient monitoring wearables for real-time data transmission
5.2. Deployment of 5G-enabled ultrasound probes to support high-definition mobile imaging in rural clinics
5.3. Adoption of network slicing for prioritizing critical patient data traffic in hospital 5G networks
5.4. Development of ultra-low latency 5G surgical robots to enable remote telesurgery with haptic feedback
5.5. Implementation of 5G-powered AI algorithms for predictive maintenance of in-hospital medical equipment
5.6. Integration of 5G-enabled telepharmacy solutions to support remote medication management in care homes
5.7. Use of 5G connectivity to stream continuous patient biometric data securely to cloud-based analytics platforms
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. 5G-enabled Medical Devices Market, by Product Type
8.1. Diagnostic Devices
8.1.1. Imaging Diagnostics
8.1.1.1. CT Scanners
8.1.1.2. MRI Scanners
8.1.1.3. Ultrasound Devices
8.1.2. Laboratory Diagnostics
8.1.2.1. Blood Analyzer
8.1.2.2. Urinalysis Analyzer
8.1.3. Point Of Care Diagnostics
8.2. Monitoring Devices
8.2.1. Cardiac Monitoring
8.2.1.1. Home Cardiac Monitoring
8.2.1.2. Hospital Cardiac Monitoring
8.2.2. Glucose Monitoring
8.2.2.1. Continuous Glucose Monitoring
8.2.2.2. Intermittent Glucose Monitoring
8.2.3. Respiratory Monitoring
8.2.3.1. Sleep Apnea Monitoring
8.2.3.2. Spirometry Monitoring
8.2.4. Vital Signs Monitoring
8.2.4.1. Blood Pressure Monitoring
8.2.4.2. Heart Rate Monitoring
8.2.4.3. Temperature Monitoring
8.3. Therapeutic Devices
8.3.1. Infusion Pumps
8.3.1.1. Insulin Infusion
8.3.1.2. Pain Management Infusion
8.3.2. Insulin Pumps
8.3.2.1. Patch Pumps
8.3.2.2. Tubed Pumps
8.3.3. Neurostimulators
8.3.3.1. Deep Brain Stimulators
8.3.3.2. Spinal Cord Stimulators
8.3.4. Respiratory Therapy Devices
8.3.4.1. CPAP Machines
8.3.4.2. Ventilators
9. 5G-enabled Medical Devices Market, by Application
9.1. Asset Tracking
9.1.1. Device Tracking
9.1.1.1. Equipment Positioning
9.1.1.2. Wearable Asset Tracking
9.1.2. Supply Chain Monitoring
9.1.2.1. Cold Chain Monitoring
9.1.2.2. Inventory Visibility
9.2. Emergency Response
9.2.1. Ambulance Services
9.2.1.1. Mobile Diagnostics
9.2.1.2. Prehospital Telehealth
9.2.2. Disaster Management
9.2.2.1. Field Hospital Enablement
9.2.2.2. Remote Coordination
9.3. Remote Patient Monitoring
9.3.1. Chronic Disease Management
9.3.1.1. Cardiac Care
9.3.1.2. Diabetes Management
9.3.2. Elderly Care
9.3.2.1. Activity Monitoring
9.3.2.2. Fall Detection
9.3.3. Postoperative Care
9.3.3.1. Pain Management
9.3.3.2. Wound Monitoring
9.4. Smart Hospital
9.4.1. Asset Management
9.4.1.1. Equipment Tracking
9.4.1.2. Inventory Management
9.4.2. Real-Time Location Services
9.4.2.1. Asset Tracking
9.4.2.2. Patient Tracking
9.4.3. Staff Management
9.4.3.1. Personnel Tracking
9.4.3.2. Workflow Optimization
9.5. Telemedicine
9.5.1. Emergency Teleconsultation
9.5.1.1. Ambulance Telehealth
9.5.1.2. Disaster Telecare
9.5.2. Video Consultation
9.5.2.1. AI-Assisted Diagnostics
9.5.2.2. Real-Time HD Video
9.5.3. Virtual ICU
9.5.3.1. Alarm Management
9.5.3.2. Remote Patient Surveillance
10. 5G-enabled Medical Devices Market, by End User
10.1. Ambulatory Surgical Centers
10.1.1. Hospital-Affiliated
10.1.2. Independent
10.2. Clinics
10.2.1. Outpatient Clinics
10.2.2. Specialty Clinics
10.3. Home Healthcare
10.3.1. Patient Homes
10.3.2. Senior Care Facilities
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
10.5. Telehealth Providers
10.5.1. Platform Providers
10.5.2. Service Aggregators
11. 5G-enabled Medical Devices Market, by Connectivity Type
11.1. NonStandalone 5G
11.1.1. MmWave
11.1.2. Sub6GHz
11.2. Private 5G
11.2.1. Campus Network
11.2.2. Industrial Network
11.3. Standalone 5G
11.3.1. MmWave
11.3.2. Sub6GHz
12. 5G-enabled Medical Devices Market, by Network Architecture
12.1. Hybrid Network
12.1.1. Edge Integrated
12.1.2. On-Premise Core
12.2. Private Network
12.2.1. Campus Network
12.2.2. Enterprise Network
12.3. Public Network
12.3.1. MVNO
12.3.2. Operator Network
13. 5G-enabled Medical Devices Market, by Component
13.1. Hardware
13.1.1. Antennas
13.1.2. Modules
13.1.2.1. Connectivity Modules
13.1.2.2. Power Modules
13.1.3. Sensors
13.2. Services
13.2.1. Consulting Services
13.2.2. Integration Services
13.2.3. Maintenance Services
13.3. Software
13.3.1. Analytics Software
13.3.2. Mobility Applications
13.3.3. Platforms
14. 5G-enabled Medical Devices Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. 5G-enabled Medical Devices Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. 5G-enabled Medical Devices Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. General Electric Company
17.3.2. Siemens Healthineers AG
17.3.3. Koninklijke Philips N.V.
17.3.4. Medtronic plc
17.3.5. Johnson & Johnson
17.3.6. Abbott Laboratories
17.3.7. Becton, Dickinson and Company
17.3.8. Baxter International Inc.
17.3.9. Boston Scientific Corporation
17.3.10. Samsung Electronics Co., Ltd

Companies Mentioned

The companies profiled in this 5G-enabled Medical Devices market report include:
  • General Electric Company
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Johnson & Johnson
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Samsung Electronics Co., Ltd

Table Information